The Clinical Outcome of Patients with Refractory/Relapsed Lymphoid Blastic Phase of Chronic Myeloid Leukemia Treated with CAR T-Cells Therapy

被引：0
|
作者：
Liu, Yujie [1 ,2 ]
Tu, Yuqing [1 ,2 ]
Xiao, Jinyan [1 ,2 ]
Shen, Yifan [2 ]
Zhou, Biqi [1 ,2 ]
Yang, Qiannan [1 ,2 ]
Liu, Tianhui [1 ,2 ]
Qi, Lijuan [1 ,2 ]
Chen, Jia [1 ,2 ]
Yu, Lei [3 ]
Wu, Depei [1 ,2 ]
Yang, Xu [1 ,2 ]
机构：
[1] Inst Blood & Marrow Transplantat, Collaborat Innovat Ctr Hematol, Suzhou, Peoples R China
[2] Soochow Univ, Affiliated Hosp 1, Natl Clin Res Ctr Hematol Dis, Jiangsu Inst Hematol, Suzhou, Peoples R China
[3] Shanghai Unicar Therapy Biomed Technol Co Ltd, Shanghai, Peoples R China
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-190741
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Functional Characterization of NK- and T-cells in IFN-a Monotherapy Treated Chronic Myeloid Leukemia (CML) Patients
    Ilander, M.
    Kreutzman, A.
    Rohon, P.
    Melo, T.
    Vakkila, J.
    Porkka, K.
    Mustjoki, S.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S179 - S180
  • [42] First-in-human phase I study of CLL-1 CAR-T cells in adults with relapsed/refractory acute myeloid leukemia
    Xin Jin
    Meng Zhang
    Rui Sun
    Hairong Lyu
    Xia Xiao
    Xiaomei Zhang
    Fan Li
    Danni Xie
    Xia Xiong
    Jiaxi Wang
    Wenyi Lu
    Hongkai Zhang
    Mingfeng Zhao
    Journal of Hematology & Oncology, 15
  • [43] First-in-human phase I study of CLL-1 CAR-T cells in adults with relapsed/refractory acute myeloid leukemia
    Jin, Xin
    Zhang, Meng
    Sun, Rui
    Lyu, Hairong
    Xiao, Xia
    Zhang, Xiaomei
    Li, Fan
    Xie, Danni
    Xiong, Xia
    Wang, Jiaxi
    Lu, Wenyi
    Zhang, Hongkai
    Zhao, Mingfeng
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2022, 15 (01)
  • [44] A phase II study of bisantrene in patients with relapsed/refractory acute myeloid leukemia
    Canaani, Jonathan
    Danylesko, Ivetta
    Shemtov, Noga
    Zlotnick, Maya
    Lozinsky, Kira
    Benjamini, Ohad
    Yerushalmi, Ronit
    Nagar, Meital
    Dor, Chen
    Shimoni, Avichai
    Avigdor, Abraham
    Nagler, Arnon
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 106 (02) : 260 - 266
  • [45] A new combination therapy with topotecan, cytarabine and mitoxantrone in patients with refractory or relapsed acute myeloid leukemia or blast crisis of chronic myeloid leukemia.
    Höchsmann, B
    Griesshammer, M
    Bergmann, L
    BLOOD, 1999, 94 (10) : 230B - 230B
  • [46] A Phase II Study of Bisantrene in Patients with Relapsed/Refractory Acute Myeloid Leukemia
    Canaani, Jonathan
    Danilesko, Ivetta
    Shem-Tov, Noga
    Zlotnick, Maya
    Lozinsky, Kira
    Benjamini, Ohad
    Yerushalmi, Ronit
    Nagar, Meital
    Dor, Chen
    Shimoni, Avichai
    Avigdor, Abraham
    Nagler, Arnon
    BLOOD, 2020, 136
  • [47] Neuroendocrine tumor of cecum in patient treated with imatinib mesylate for blastic phase of chronic myeloid leukemia
    Novakovic, Sabina
    Peic, Anamarija Kovac
    Holik, Hrvoje
    Coha, Bozena
    ACTA CLINICA BELGICA, 2017, 72 (06) : 461 - 464
  • [48] Monitoring response and treatment outcome in patients with chronic phase chronic myeloid leukemia (CML) treated with imatinib
    Teitelbaum, A.
    Spencer, D.
    Bollu, V. K.
    Chastek, B.
    Coombs, J.
    Kulakodlu, M.
    Morlock, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [49] Therapy related acute myeloid leukemia secondary to CAR-T therapy in refractory/relapsed multiple myeloma patient showing poor prognosis
    An, Ran
    Bao, Weiying
    Yan, Zeying
    Sun, Haimin
    Xu, Xiaoqian
    Zhang, Sujiang
    ANNALS OF HEMATOLOGY, 2025,
  • [50] Identification and clinical implications of recurrent PAX5::MLLT3 fusion in lymphoid blastic phase chronic myeloid leukemia
    Wang, Lijun
    Chen, Yu
    Wang, Qingyuan
    Xiang, Meng
    Zeng, Zhao
    Zhang, Zhibo
    Zhang, Fenghong
    Chen, Suning
    Xue, Mengxing
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2024, 46 (03) : 571 - 574
12345